MRKR

1.47

3.52% 0.05

Handel nachbörslich: 1.42 -0.05 -3.40%

Marker Therapeutics Inc (MRKR)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.42

Offen:

$1.45

24-Stunden-Volumen:

251.82K

Relative Volume:

0.94

Marktkapitalisierung:

$24.51M

Einnahmen:

Nettoeinkommen (Verlust:

$-9.70M

KGV:

-1.3364

EPS:

-1.1

Netto-Cashflow:

$-8.57M

1W Leistung:

+11.36%

1M Leistung:

+55.79%

6M Leistung:

-13.02%

1J Leistung:

-68.86%

1-Tages-Spanne:

$1.42

$1.48

1-Wochen-Bereich:

$1.31

$1.49

52-Wochen-Spanne:

$0.8099

$5.95

Marker Therapeutics Inc Stock (MRKR) Company Profile

Firmenname

Marker Therapeutics Inc

Sektor

Healthcare (1123)

Branche

Biotechnology (627)

Telefon

(713) 400-6400

Adresse

2450 HOLCOMBE BLVD, HOUSTON, TX

Mitarbeiter

Twitter

@MRKRTherapeutic

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

MRKR's Discussions on Twitter

Vergleichen Sie MRKR mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MRKR Marker Therapeutics Inc	1.47	23.68M	0	-9.70M	-8.57M	-1.10
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-05	Eingeleitet	Canaccord Genuity	Buy
2021-03-25	Eingeleitet	Piper Sandler	Overweight
2021-03-19	Eingeleitet	Cantor Fitzgerald	Overweight
2020-05-12	Herabstufung	Piper Sandler	Overweight → Neutral
2019-05-30	Eingeleitet	ROTH Capital	Buy
2019-03-01	Eingeleitet	Janney	Buy
2018-12-03	Hochstufung	Piper Jaffray	Neutral → Overweight

Alle ansehen

Marker Therapeutics Inc Aktie (MRKR) Neueste Nachrichten

02:40 AM

Panic Selling: Is Marker Therapeutics Inc stock supported by strong cash flows2025 Pullback Review & Reliable Momentum Entry Alerts - moha.gov.vn

02:40 AM

Dec 12, 2025

Published on: 2025-12-13 20:42:44 - moha.gov.vn

Dec 12, 2025

Dec 11, 2025

What drives Marker Therapeutics Inc GX1 stock priceDividend Stability Analysis & Consistent Triple Returns - earlytimes.in

Dec 11, 2025

FY2025 Earnings Forecast for MRKR Issued By HC Wainwright - Defense World

Dec 11, 2025

Dec 10, 2025

Marker Therapeutics (NASDAQ:MRKR) Coverage Initiated at HC Wainwright - Defense World

Dec 10, 2025

Dec 08, 2025

H.C. Wainwright reiterates Buy rating on Marker Therapeutics stock By Investing.com - Investing.com Canada

Dec 08, 2025

HC Wainwright & Co. Initiates Coverage of Marker Therapeutics (MRKR) with Buy Recommendation - Nasdaq

Dec 08, 2025

MRKR: HC Wainwright & Co. Initiates Coverage with a 'Buy' Rating - GuruFocus

Dec 08, 2025

Dec 06, 2025

Is Marker Therapeutics Inc GX1 a good long term investmentExit Strategy Tips & Never Miss the Next Wealth Opportunity - earlytimes.in

Dec 06, 2025

Dec 05, 2025

Check Out Lam Research Corp (LRCX)’s Trade Data Rather Than the Analysts’ Views - setenews.com

Dec 05, 2025

Why Marker Therapeutics Inc. stock remains on watchlistsWeekly Trend Report & AI Forecasted Stock Moves - Newser

Dec 05, 2025

Dec 04, 2025

How analysts revise price targets for Marker Therapeutics Inc. (GX1) stockJuly 2025 Patterns & Precise Swing Trade Entry Alerts - Newser

Dec 04, 2025

Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Business Upturn

Dec 04, 2025

Is Marker Therapeutics Inc. stock supported by innovation pipelineMarket Performance Recap & Advanced Technical Signal Analysis - Newser

Dec 04, 2025

Is Marker Therapeutics Inc. (GX1) stock good for long term investingJuly 2025 PostEarnings & Safe Entry Trade Reports - Newser

Dec 04, 2025

Why ETFs are accumulating Marker Therapeutics Inc. (GX1) stockProduct Launch & Safe Entry Trade Signal Reports - Newser

Dec 04, 2025

Dec 02, 2025

Recovery Setup Building in AVI Polymers Limited Experts SayPrice-to-Earnings Ratio Insights & Capital Planning and Optimization - earlytimes.in

Dec 02, 2025

Marker Therapeutics (MRKR) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

Dec 01, 2025

Marker Therapeutics (NASDAQ:MRKR) Downgraded by Wall Street Zen to Sell - Defense World

Dec 01, 2025

Nov 28, 2025

What insider trading reveals about Marker Therapeutics Inc. stockWeekly Trading Summary & High Accuracy Swing Entry Alerts - moha.gov.vn

Nov 28, 2025